Aminophylline for the prevention of apnea during prostaglandin E1 infusion.

Pediatrics

Volumn 112, Issue 1 Pt 1, 2003, Pages

  Lim, D S ^a   Kulik, Thomas J ^a   Kim, Dennis W ^a   Charpie, John R ^a   Crowley, Dennis C ^a   Maher, Kevin O ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; BRONCHODILATING AGENT; HYPNOTIC SEDATIVE AGENT; PROSTAGLANDIN E1;

ANOXIA; APNEA; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTRACHEAL INTUBATION; HUMAN; IRRITABILITY; LENGTH OF STAY; MULTICENTER STUDY; NEWBORN; PALLIATIVE THERAPY; PATENT DUCTUS ARTERIOSUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ALPROSTADIL; AMINOPHYLLINE; ANOXIA; APNEA; BRADYCARDIA; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; DUCTUS ARTERIOSUS, PATENT; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; INTUBATION, INTRATRACHEAL; IRRITABLE MOOD; LENGTH OF STAY; PALLIATIVE CARE; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0642314258     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.112.1.e27     Document Type: Article

References (0)